Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Diabetes and Cardiovascular Disease
1999 Standout
Infection, inflammation, height, and longevity
2005 Standout
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
1999 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance
2003
Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
2005
Triglycerides and Cardiovascular Disease
2011
Uptake of lipophilic drugs by plasma derived isolated chylomicrons: Linear correlation with intestinal lymphatic bioavailability
2005
Postprandial lipoprotein metabolism and atherosclerosis
1999
Impaired postprandial apolipoprotein-B48 metabolism in the obese, insulin-resistant JCR:LA-cp rat: Increased atherogenicity for the metabolic syndrome
2006
Red wine mitigates the postprandial increase of LDL susceptibility to oxidation
2001
The atherogenic plasma remnant‐like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients
2001
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
The metabolic syndrome
2010 Standout
Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation
2006 Standout
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
2002 Standout
Unravelling the familial tendency to aneurysmal disease: Popliteal aneurysm, hypertension and fibrillin genotype
1996
Antibiotics Suppress Activation of Intestinal Mucosal Mast Cells and Reduce Dietary Lipid Absorption in Sprague-Dawley Rats
2016
Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases
2009 Standout
Interaction between microbiota and immunity in health and disease
2020 Standout
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
The metabolic syndrome
2005 Standout
GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects
2009
Role of Oxidative Modifications in Atherosclerosis
2004 Standout
COPII-coated vesicles: flexible enough for large cargo?
2005 StandoutNobel
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
1999 Standout
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice
2000
Serum Triglycerides as a Risk Factor for Cardiovascular Diseases in the Asia-Pacific Region
2004
The immune response in atherosclerosis: a double-edged sword
2006 Standout
Prevalence of the Metabolic Syndrome Among US Adults
2002 Standout
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
1992
Prescribing Aerobic Exercise for the Regulation of Postprandial Lipid Metabolism
2006
Effects of dietary saturated, monounsaturated and n-3 fatty acids on fasting lipoproteins, LDL size and post-prandial lipid metabolism in healthy subjects
2003
Postprandial Glucose Regulation and Diabetic Complications
2004
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women
2009 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
The intracellular transport of chylomicrons requires the small GTPase, Sar1b
2004
Obesity as a medical problem
2000 StandoutNature
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
LDL subfractions in acromegaly: relation to growth hormone and insulin-like growth factor-I
1997
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
2003
Cardiovascular Disease Under the Influence of Excess Visceral Fat
2007
New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis
1996
Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials
2003 Standout
Vitamin E Consumption and the Risk of Coronary Disease in Women
1993 Standout
Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis
2002
Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on postprandial endothelial function
1999
Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: Cause, consequence, or epiphenomenon?
2006 Standout
New Insights into Lipid Metabolism in Non-insulin-dependent Diabetes Mellitus
1996
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Activation of Oxidative Stress by Acute Glucose Fluctuations Compared With Sustained Chronic Hyperglycemia in Patients With Type 2 Diabetes
2006 Standout
Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
2011
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease
1998
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Postprandial Lipemia Associates with Liver Fat Content
2007
Exercise and Physical Activity for Older Adults
2009 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Endothelial Nitric Oxide Synthase in Vascular Disease
2006 Standout
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
2001 Standout
Are Increased Plasma Non-Esterified Fatty Acid Concentrations a Risk Marker for Coronary Heart Disease and other Chronic Diseases?
1996
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Postprandial Hyperglycemia and Diabetes Complications
2005
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Alimentary Lipemia, Postprandial Triglyceride-Rich Lipoproteins, and Common Carotid Intima-Media Thickness in Healthy, Middle-Aged Men
1999
Lipoprotein Subclasses and Particle Sizes and Their Relationship With Coronary Artery Calcification in Men and Women With and Without Type 1 Diabetes
2002
Abdominal Obesity and Dyslipidemia in the Metabolic Syndrome: Importance of Type 2 Diabetes and Familial Combined Hyperlipidemia in Coronary Artery Disease Risk
2004
Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies
1996 Standout
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Influence of Folic Acid on Postprandial Endothelial Dysfunction
2000
Small, Dense Low-Density Lipoprotein Particles as a Predictor of the Risk of Ischemic Heart Disease in Men
1997
The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis
2000
Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with Lp(a).
1993
Echolucent, rupture-prone carotid plaques associated with elevated triglyceride-rich lipoproteins, particularly in women
2002
The Metabolic Syndrome
2008 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Detection, Quantification, and Characterization of Potentially Atherogenic Triglyceride-Rich Remnant Lipoproteins
1999
Chs5/6 Complex: A Multiprotein Complex That Interacts with and Conveys Chitin Synthase III from theTrans-Golgi Network to the Cell Surface
2006 StandoutNobel
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
2002 Standout
A Prospective Study of Triglyceride Level, Low-Density Lipoprotein Particle Diameter, and Risk of Myocardial Infarction
1996
Dietary Fish Oil (4 g Daily) and Cardiovascular Risk Markers in Healthy Men
1997
Works of Anders Hamsten being referenced
Magnitude of alimentary lipemia is related to intima-media thickness of the common carotid artery in middle-aged men
1998
Relationships of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction
1991
Identification of genetic variation that determines levels of plasma triglycerides and hypercoagulability
1994
Postprandial lipoproteins and progression of coronary atherosclerosis
1994
[5] Apolipoprotein B-48
1996
Differences in postprandial concentrations of very—low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease
1999